3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
6
INDUSTRY
5
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Recurrent Squamous Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Prostatic Diseases
1
Lung Neoplasms
1
ATM Gene Mutation
1
Interventions
bicalutamide
23
Radiotherapy
21
Goserelin
21
Docetaxel
19
Flutamide
17
Leuprolide
16
Prednisone
11
Radiotherapy, Conformal
10
Gonadotropin-Releasing Hormone
10
Radiotherapy, Intensity-Modulated
9
Triptorelin Pamoate
8
Buserelin
8
Estramustine
7
Androgen Antagonists
7
Brachytherapy
6
luprolide acetate gel depot
5
enzalutamide
5
Paclitaxel
5
nilutamide
4
darolutamide
4
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
4
Radiation
4
Mitoxantrone
4
Carboplatin
4
orteronel
3
apalutamide
3
Selenium
3
Orchiectomy
3
Magnetic Resonance Spectroscopy
3
Iodine-125
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Prostatic Neoplasms
×
talazoparib
×
Clear all
NCT06582628
2024-12-02
TEAM PC
Fundacion Oncosur
Phase 2
Recruiting
78 enrolled